These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 18959062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gaucher disease: an overview of clinical characteristics and therapy.
    Kingma W.
    J Intraven Nurs; 1996; 19(2):79-82. PubMed ID: 8852167
    [Abstract] [Full Text] [Related]

  • 5. [Gaucher disease: diagnosis and treatment].
    Fumić K, Stavljenić-Rukavina A, Mrsić M, Potocki K.
    Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
    [Abstract] [Full Text] [Related]

  • 6. Gaucher disease: from fundamental research to effective therapeutic interventions.
    de Fost M, Aerts JM, Hollak CE.
    Neth J Med; 2003 Jan; 61(1):3-8. PubMed ID: 12688562
    [Abstract] [Full Text] [Related]

  • 7. [Update on Gaucher's disease].
    Virgolini L, Silvestri F, Baccarani M.
    Minerva Med; 1993 Mar; 84(3):81-7. PubMed ID: 8492969
    [Abstract] [Full Text] [Related]

  • 8. Gaucher's disease: a review for the internist and hepatologist.
    Niederau C, Häussinger D.
    Hepatogastroenterology; 2000 Mar; 47(34):984-97. PubMed ID: 11020862
    [Abstract] [Full Text] [Related]

  • 9. Miglustat: new drug. In type 1 Gaucher's disease : a slight benefit after imiglucerase therapy.
    Prescrire Int; 2005 Oct; 14(79):168-70. PubMed ID: 16285070
    [Abstract] [Full Text] [Related]

  • 10. [Gaucher's disease. Report of 4 cases].
    Adarraga Cansino MD, Fernández de la Puebla R, Jiménez Perepérez JA, Pocoví Mieras M, Zambrana García JL, Pérez Jiménez F.
    Rev Clin Esp; 2002 Dec; 202(12):635-7. PubMed ID: 12459090
    [Abstract] [Full Text] [Related]

  • 11. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.
    Mistry PK, Sadan S, Yang R, Yee J, Yang M.
    Am J Hematol; 2007 Aug; 82(8):697-701. PubMed ID: 17492645
    [Abstract] [Full Text] [Related]

  • 12. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S, Roberts A, Patterson MA, Amato D.
    Blood Cells Mol Dis; 2009 Aug; 43(3):289-93. PubMed ID: 19793665
    [Abstract] [Full Text] [Related]

  • 13. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
    Di Rocco M, Giona F, Carubbi F, Linari S, Minichilli F, Brady RO, Mariani G, Cappellini MD.
    Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565
    [Abstract] [Full Text] [Related]

  • 14. [Gaucher disease--guidelines for diagnosis and management of adult patients].
    Merkler M, Simić I, Pećin I, Muacević-Katanec D, Sucur N, Reiner Z.
    Lijec Vjesn; 2014 Aug; 136(5-6):130-3. PubMed ID: 25154180
    [Abstract] [Full Text] [Related]

  • 15. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A, Marzouk I, El-Shayeb A, Wali Y.
    Pediatr Hematol Oncol; 2006 Aug; 23(5):411-7. PubMed ID: 16728361
    [Abstract] [Full Text] [Related]

  • 16. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
    Mikosch P.
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
    [Abstract] [Full Text] [Related]

  • 17. The long-term international safety experience of imiglucerase therapy for Gaucher disease.
    Starzyk K, Richards S, Yee J, Smith SE, Kingma W.
    Mol Genet Metab; 2007 Feb; 90(2):157-63. PubMed ID: 17079176
    [Abstract] [Full Text] [Related]

  • 18. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P, Andersson HC, Kacena KA, Yee JD.
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.
    Kishnani PS, DiRocco M, Kaplan P, Mehta A, Pastores GM, Smith SE, Puga AC, Lemay RM, Weinreb NJ.
    Mol Genet Metab; 2009 Apr; 96(4):164-70. PubMed ID: 19195916
    [Abstract] [Full Text] [Related]

  • 20. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
    Charrow J, Dulisse B, Grabowski GA, Weinreb NJ.
    Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.